• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌肝转移:在欧乃影肝胆磁共振成像时代的消失病灶

Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging.

作者信息

Owen Joseph W, Fowler Kathryn J, Doyle Maria B, Saad Nael E, Linehan David C, Chapman William C

机构信息

University of Kentucky, Department of Radiology, United States.

Washington University, Department of Radiology, United States.

出版信息

HPB (Oxford). 2016 Mar;18(3):296-303. doi: 10.1016/j.hpb.2015.10.009. Epub 2016 Mar 14.

DOI:10.1016/j.hpb.2015.10.009
PMID:27017170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4814600/
Abstract

BACKGROUND

Hepatobiliary contrast enhanced MRI is known to be the most sensitive imaging modality for detection of colorectal hepatic metastasis. To date no study has investigated the rate of disappearing lesions with gadoxetic acid MR (Eovist/Primovist), or characterized the pathologic response of lesions which disappear on gadoxetic acid MR.

METHODS

Retrospective review of hepatic resections for colorectal metastases between 01/2008 and 01/2014 was performed to evaluated the rate of disappearance of lesions on gadoxetic acid MR and the rate of complete pathologic response in the lesions that disappear. "Disappearing lesions" were lesions on baseline imaging that were not identifiable on pre-operative Eovist MRI. Complete pathologic response was defined as no viable tumor on pathology or by lack of recurrence within 1 year.

RESULTS

In 23 patients, 200 colorectal metastases were identified on baseline imaging. On pre-operative Eovist MR 77 of the 200 lesions (38.5%) were "disappearing" lesions. At surgical pathology or 1 year follow-up imaging, 42 of 77 lesions (55%) demonstrated viable tumor (21) or recurrence (21). Thirty of 77 lesions (39%) were nonviable at pathology (10) or without evidence of recurrence at 1 year (20). 5 lesions were indeterminate.

DISCUSSION

Despite disappearance on Eovist MR imaging (the most sensitive available imaging modality), 38.5% of all colorectal metastases disappeared and of those, 55% were viable.

摘要

背景

肝胆对比增强磁共振成像(MRI)是检测结直肠癌肝转移最敏感的成像方式。迄今为止,尚无研究调查钆塞酸二钠磁共振成像(Eovist/Primovist)中病灶消失的发生率,或对钆塞酸二钠磁共振成像上消失的病灶的病理反应进行特征描述。

方法

对2008年1月至2014年1月期间因结直肠癌肝转移行肝切除术的病例进行回顾性分析,以评估钆塞酸二钠磁共振成像上病灶消失的发生率以及消失病灶的完全病理缓解率。“消失的病灶”是指基线成像上存在但术前Eovist磁共振成像上未发现的病灶。完全病理缓解定义为病理检查无存活肿瘤或1年内无复发。

结果

23例患者基线成像上共发现200个结直肠癌肝转移灶。术前Eovist磁共振成像上,200个病灶中有77个(38.5%)为“消失”病灶。手术病理或1年随访成像时,77个病灶中有42个(55%)显示有存活肿瘤(21个)或复发(21个)。77个病灶中有30个(39%)病理检查无存活肿瘤(10个)或1年时无复发证据(20个)。5个病灶情况不确定。

讨论

尽管在Eovist磁共振成像(最敏感的现有成像方式)上病灶消失,但所有结直肠癌肝转移灶中有38.5%消失,其中55%有存活肿瘤。

相似文献

1
Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging.结直肠癌肝转移:在欧乃影肝胆磁共振成像时代的消失病灶
HPB (Oxford). 2016 Mar;18(3):296-303. doi: 10.1016/j.hpb.2015.10.009. Epub 2016 Mar 14.
2
Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography.在肝细胞特异性磁共振成像和术中超声造影时代,结直肠癌肝转移灶消失的临床意义已经发生了变化。
HPB (Oxford). 2018 Aug;20(8):708-714. doi: 10.1016/j.hpb.2018.02.377. Epub 2018 Mar 10.
3
Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities.结直肠癌肝转移灶消失:现代成像方式的影响
HPB (Oxford). 2015 Nov;17(11):983-7. doi: 10.1111/hpb.12476. Epub 2015 Aug 7.
4
Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.扩散加权和肝胆期钆塞酸二钠增强定量磁共振成像用于识别术前化疗后结直肠癌肝转移的完全病理缓解
Abdom Radiol (NY). 2016 Feb;41(2):231-8. doi: 10.1007/s00261-015-0572-z.
5
Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan.钆塞酸二钠增强肝脏MRI与对比增强CT对化疗后结直肠癌肝转移术前检测的前瞻性比较及其与组织病理学的相关性以及对手术计划的潜在影响。
HPB (Oxford). 2017 Nov;19(11):992-1000. doi: 10.1016/j.hpb.2017.06.014. Epub 2017 Jul 29.
6
Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.结直肠癌肝转移化疗后消失性病灶的管理:可检测性与残留肿瘤之间的关系
J Surg Oncol. 2018 Feb;117(2):191-197. doi: 10.1002/jso.24805. Epub 2017 Sep 6.
7
Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.使用影像学预测结直肠癌肝转移化疗后完全缓解:磁共振成像与 CT 成像的比较。
Radiology. 2017 Aug;284(2):423-431. doi: 10.1148/radiol.2017161619. Epub 2017 Mar 22.
8
Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?经钆塞酸二钠增强肝脏磁共振成像(MRI)和扩散加权成像检查,化疗后消失或残留的微小(≤5毫米)结直肠癌肝转移灶:是否需要局部治疗?
Eur Radiol. 2017 Jul;27(7):3088-3096. doi: 10.1007/s00330-016-4644-4. Epub 2016 Nov 4.
9
Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.对比增强术中超声在识别化疗后结直肠癌肝转移灶消失中的应用价值
Ann Surg Oncol. 2014 Jun;21 Suppl 3:S390-7. doi: 10.1245/s10434-014-3576-y. Epub 2014 Feb 26.
10
Management of disappearing colorectal liver metastases.结直肠癌肝转移灶消失的处理
Eur J Surg Oncol. 2016 Dec;42(12):1798-1805. doi: 10.1016/j.ejso.2016.05.005. Epub 2016 May 24.

引用本文的文献

1
The challenge of disappearing colorectal liver metastasis: balancing considerations between tumor biology and clinical consequence for liver surgery.结直肠癌肝转移灶消失的挑战:权衡肿瘤生物学与肝脏手术临床后果之间的考量
Clin Exp Metastasis. 2025 Jul 12;42(4):39. doi: 10.1007/s10585-025-10357-y.
2
Gadoxetic acid-enhanced magnetic resonance imaging to predict pathologic complete response of colorectal liver metastases in preoperative chemotherapy.钆塞酸二钠增强磁共振成像预测结直肠癌肝转移术前化疗的病理完全缓解
Sci Rep. 2025 Jul 2;15(1):22632. doi: 10.1038/s41598-025-08243-4.
3
A Systematic Review of Disappearing Colorectal Liver Metastases: Resection or No Resection?结直肠癌肝转移灶消失:切除还是不切除?一项系统综述
J Clin Med. 2025 Feb 10;14(4):1147. doi: 10.3390/jcm14041147.
4
New trends in surgery for colorectal liver metastasis.结直肠癌肝转移手术的新趋势
Ann Gastroenterol Surg. 2024 Apr 26;8(4):553-565. doi: 10.1002/ags3.12810. eCollection 2024 Jul.
5
Contemporary Surgical Management of Colorectal Liver Metastases.结直肠癌肝转移的现代外科治疗
Cancers (Basel). 2024 Feb 26;16(5):941. doi: 10.3390/cancers16050941.
6
Exploring the Outcome of Disappearance or Small Remnants of Colorectal Liver Metastases during First-Line Chemotherapy on Hepatobiliary Contrast-Enhanced and Diffusion-Weighted MR Imaging.探索结直肠癌肝转移瘤在一线化疗期间消失或残留小病灶在肝胆对比增强磁共振成像和扩散加权磁共振成像上的表现
Cancers (Basel). 2023 Apr 8;15(8):2200. doi: 10.3390/cancers15082200.
7
Retrospective analysis of colorectal cancer patients with metachronous initially unresectable liver metastases (and no other) achieving no evidence of disease after first-line comprehensive therapy: a multicenter real-world study.一线综合治疗后首次达到无疾病证据的初诊不可切除肝转移(且无其他部位转移)结直肠癌患者的回顾性分析:一项多中心真实世界研究。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8403-8413. doi: 10.1007/s00432-023-04768-1. Epub 2023 Apr 21.
8
Disappearing Colorectal Liver Metastases: Do We Really Need a Ghostbuster?消失的结直肠癌肝转移灶:我们真的需要捉鬼敢死队吗?
Healthcare (Basel). 2022 Sep 28;10(10):1898. doi: 10.3390/healthcare10101898.
9
The Influence of Radiological "Disappearing Lesions" on the Efficacy and Prognosis of Patients with Colorectal Liver Metastases Undergoing Conversion Therapy.放射学“消失病灶”对接受转化治疗的结直肠癌肝转移患者疗效和预后的影响
Gastroenterol Res Pract. 2022 Feb 22;2022:2200598. doi: 10.1155/2022/2200598. eCollection 2022.
10
Colorectal liver metastases: Current management and future perspectives.结直肠癌肝转移:当前治疗与未来展望
World J Clin Oncol. 2020 Oct 24;11(10):761-808. doi: 10.5306/wjco.v11.i10.761.

本文引用的文献

1
Surgical management of disappearing colorectal liver metastases.结直肠肝转移瘤的外科治疗。
Br J Surg. 2013 Oct;100(11):1414-20. doi: 10.1002/bjs.9213. Epub 2013 Aug 16.
2
Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.结直肠癌肝转移的术前评估:与增强 MDCT 比较,钆塞酸二钠增强 3.0T MRI 的术前评估:与组织病理学相关性。
Eur Radiol. 2013 Aug;23(8):2187-96. doi: 10.1007/s00330-013-2824-z. Epub 2013 Mar 22.
3
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.贝伐珠单抗联合 FOLFOX 或 FOLFIRI 一线治疗转移性结直肠癌患者的治疗模式和临床结局:来自贝伐珠单抗观察性队列研究 ARIES 的结果。
Oncologist. 2012;17(12):1486-95. doi: 10.1634/theoncologist.2012-0190. Epub 2012 Sep 26.
4
Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease.术中检测结直肠肝转移灶消失作为残留疾病的预测指标。
J Gastrointest Surg. 2012 Apr;16(4):806-14. doi: 10.1007/s11605-011-1810-5. Epub 2012 Jan 19.
5
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
6
Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging.检测和特征分析结直肠癌患者肝内局灶性病变:弥散加权成像与钆塞酸二钠增强磁共振成像的对比研究。
Eur Radiol. 2011 Apr;21(4):832-40. doi: 10.1007/s00330-010-1977-2. Epub 2010 Oct 2.
7
Disappearing colorectal liver metastases after chemotherapy: should we be concerned?化疗后结直肠肝转移灶消失:我们是否应该担心?
J Gastrointest Surg. 2010 Nov;14(11):1691-700. doi: 10.1007/s11605-010-1348-y. Epub 2010 Sep 14.
8
Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy.化疗后结直肠癌肝转移消失后真正完全缓解的预测因素。
Cancer. 2010 Mar 15;116(6):1502-9. doi: 10.1002/cncr.24912.
9
Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases.术前化疗完全病理缓解对结直肠癌肝转移治疗的重要性。
Ann Surg. 2009 Dec;250(6):935-42. doi: 10.1097/sla.0b013e3181b0c6e4.
10
Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin.化疗完全缓解后肝切除术后遗漏的结直肠癌肝转移灶的转归:肝动脉内奥沙利铂辅助治疗的影响
Ann Surg Oncol. 2007 Nov;14(11):3188-94. doi: 10.1245/s10434-007-9482-9. Epub 2007 Aug 20.